Physician profile
Nupur Kumar
NPI 1265514129
$6,539.78
in general payments reported to CMS, 2019-2025
29 companies · $589 in 2025
The $589 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $876 · 2020: $389 · 2021: $1,550 · 2022: $1,129 · 2023: $580 · 2024: $1,427 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,421 · Consulting Fee: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,420.65 |
| Consulting Fee | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,354.45 | 2021-2025 | |
| Cvrx, INC. | $674.39 | 2021-2025 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $541.74 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $517.06 | 2019-2022 | |
| Amgen INC. | $491.06 | 2019-2025 | Prolia |
| Pfizer INC. | $295.31 | 2020-2024 | |
| Abiomed | $292.89 | 2021-2024 | Impella |
| Lilly USA, LLC | $291.59 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Boston Scientific Corporation | $275.00 | 2023-2024 | Emblem Mri S-Icd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $250.00 | 2021-2025 | Lifevest |
| Inari Medical, INC. | $214.13 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $182.85 | 2021-2025 | Jardiance |
| Allergan, INC. | $156.36 | 2019-2020 | |
| Shockwave Medical, INC | $150.00 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $121.66 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $85.36 | 2021-2024 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $80.74 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $79.39 | 2019-2022 | |
| Amarin Pharma, INC. | $73.97 | 2020 | |
| Janssen Pharmaceuticals, INC | $70.67 | 2019-2024 | Xarelto |
| Astellas Pharma US INC | $65.56 | 2019 | |
| Glaxosmithkline, LLC. | $59.26 | 2022-2025 | Benlysta |
| Otsuka America Pharmaceutical, INC. | $43.52 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $41.30 | 2021 | |
| La Jolla Pharmaceutical Company | $37.12 | 2019 | |
| Merck Sharp & Dohme LLC | $30.29 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $24.46 | 2022 | |
| Radius Health, INC. | $20.34 | 2019 | |
| Hologic Sales and Service, LLC | $19.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nupur Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.